REGISTERED
on 09 Jul 2024
Last Applicant/ Owned by
JANKOVCOVA 1518/2
CZ-170 00 PRAGUE 7
CZ
Serial Number
79337464 filed on 09th Feb 2022
Registration Number
7435168 registered on 09th Jul 2024
Correspondent Address
Shane Rumbaugh
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
SCTBIO
Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy mater Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; product research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [039]
Transportation & Storage Services
Labeling, relabeling, storage and distribution of cell therapy materials
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals, to the order and specification of others
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79337464
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Jan 2025 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 13th Dec 2024 | FINAL DISPOSITION PROCESSED |
| 13th Dec 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 09th Oct 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 09th Jul 2024 | REGISTERED-PRINCIPAL REGISTER |
| 09th Jul 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 23rd Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 23rd Apr 2024 | PUBLISHED FOR OPPOSITION |
| 22nd Apr 2024 | NOTIFICATION PROCESSED BY IB |
| 03rd Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |